T-DM1 activity in metastatic HER2-positive breast cancers that received prior therapy with trastuzumab and pertuzumab.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Dzimitrowicz, HE; Berger, MJ; Vargo, C; Hood, A; Abdelghany, O; Raghavendra, AS; Tripathy, D; Valero, V; Pusztai, L; Murthy, RK

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • 585 - 585

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.585